{"id":6735,"date":"2025-05-16T17:01:01","date_gmt":"2025-05-16T15:01:01","guid":{"rendered":"https:\/\/www.institut-biotherapies.fr\/?p=6735"},"modified":"2026-02-19T17:07:57","modified_gmt":"2026-02-19T15:07:57","slug":"als-the-mirocals-trial-paves-the-way-for-a-new-treatment","status":"publish","type":"post","link":"https:\/\/www.institut-biotherapies.fr\/en\/2025\/05\/16\/als-the-mirocals-trial-paves-the-way-for-a-new-treatment\/","title":{"rendered":"ALS: The MIROCALS Trial Paves the Way for a New Treatment"},"content":{"rendered":"<p>The results of the European MIROCALS trial provide new insights into a promising therapeutic approach for Amyotrophic Lateral Sclerosis (ALS). Low-dose interleukin-2 could slow disease progression in certain patients. A study supported by AFM-T\u00e9l\u00e9thon and its laboratory, G\u00e9n\u00e9thon, through its biobank.<\/p>\n<p><a href=\"https:\/\/www.afm-telethon.fr\/en\/news\/als-mirocals-trial-paves-way-new-treatment\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The results of the European MIROCALS trial provide new insights into a promising therapeutic approach for Amyotrophic Lateral Sclerosis (ALS). Low-dose interleukin-2 could slow disease progression in certain patients. A study supported by AFM-T\u00e9l\u00e9thon and its laboratory, G\u00e9n\u00e9thon, through its biobank. Read more<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-6735","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/6735","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/comments?post=6735"}],"version-history":[{"count":1,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/6735\/revisions"}],"predecessor-version":[{"id":6736,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/6735\/revisions\/6736"}],"wp:attachment":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/media?parent=6735"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/categories?post=6735"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/tags?post=6735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}